Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Acupuncture may ease multiple symptoms in breast cancer survivors

NCT ID NCT07481903

Symptom relief Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether electroacupuncture (a type of acupuncture with mild electrical pulses) can reduce a group of common symptoms—pain, tiredness, sleep problems, anxiety, depression, and memory fogginess—in breast cancer survivors who are on hormone therapy. About 228 women will receive either real or sham acupuncture over 8 weeks. The goal is to see if real acupuncture improves at least two of these symptoms more than the sham treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 228 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria： 1. Female, aged 18-75 years; 2. Histologically confirmed Stage 0, I, II, or III breast cancer (according to the AJCC 8th edition)； 3. Completed active treatment (surgery, chemotherapy, and/or radiotherapy) at least 1 month prior to study initiation , and are currently receiving endocrine therapy； 4. Meet at least 2 of the following 6 criteria: (1)Visual Analogue Scale (VAS) score for pain ≥ 4 (2)Pittsburgh Sleep Quality Index (PSQI) score ≥ 8 (3)Brief Fatigue Inventory-Chinese version (BFI-C) score ≥ 4 (4)Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) score ≥ 8 (5)Hospital Anxiety and Depression Scale-Depression subscale (HADS-D) score ≥ 8 (6)Functional Assessment of Cancer Therapy-Cognitive Function-Perceived Cognitive Impairments (FACT-Cog-PCI) score \< 60 ; 5.Has signed the informed consent form and voluntarily participates in this study. Exclusion Criteria: 1. History of psychiatric disorders (e.g., bipolar disorder, schizophrenia, substance addiction) 2. Presence of diseases that may impair cognitive function or interfere with study assessments (e.g., Alzheimer's disease, Parkinson's disease, brain tumors). 3. Fatigue attributable to a treatable condition (e.g., hypothyroidism). 4. Severe debilitation or significant organic disease (e.g., heart failure, severe hepatic/renal insufficiency, severe anemia, uncontrolled infection). 5. Use of anxiolytics, antidepressants, psychostimulants, or sedative-hypnotics within the past 4 weeks. 6. Chronic use of corticosteroids. 7. Prior acupuncture treatment within 3 months, or participation in an acupuncture or drug clinical trial within 6 months. 8. History of hemorrhagic disease, severe coagulation dysfunction, or current use of anticoagulants (e.g., warfarin). 9. Implanted cardiac pacemaker. 10. Pregnancy or breastfeeding. 11. Concurrent participation in another clinical study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder breast cancer breast neoplasm Depression depressive disorder Fatigue insomnia Pain subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Depression Fatigue Insomnia Pain Psychoneurological symptom cluster(pain, insomnia, anxiety, fatigue, depression, subjective cognitive decline) Subjective cognitive decline (SCD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

    Tianjin, Tianjin Municipality, 300381, China

  • Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

    Nanjing, Jiangsu, 210029, China

  • Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University

    Qingdao, Shandong, 266000, China

  • Senior Department of Oncology，Chinese PLA General Hospital

    Beijing, Beijing Municipality, 100039, China

  • Tianjin Medical University Cancer Institute & Hospital (TMUCIH)

    Tianjin, Tianjin Municipality, 300060, China

  • Xiyuan Hospital of CACMS

    Beijing, Beijing Municipality, 100091, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.